Assessing the risk of refractory disease in iTTP
- 12 July 2020
- journal article
- editorial
- Published by Wiley in British Journal of Haematology
- Vol. 191 (2), 143-144
- https://doi.org/10.1111/bjh.16947
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative dataBritish Journal of Haematology, 2020
- Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpuraTransfusion, 2020
- Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpuraBlood Advances, 2019
- Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort studyThe Lancet Haematology, 2017
- Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceHaematologica, 2012
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraThe New England Journal of Medicine, 1991
- THROMBOTIC THROMBOCYTOPENIC PURPURAMedicine, 1966